InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.130
+0.007 (0.33%)
Oct 13, 2025, 4:00 PM EDT - Market closed

InMed Pharmaceuticals Revenue

In the fiscal year ending June 30, 2025, InMed Pharmaceuticals had annual revenue of $4.94M with 7.50% growth. InMed Pharmaceuticals had revenue of $1.30M in the quarter ending June 30, 2025, with 1.69% growth.

Revenue (ttm)
$4.94M
Revenue Growth
+7.50%
P/S Ratio
0.42
Revenue / Employee
$380,203
Employees
13
Market Cap
5.08M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20254.94M344.90K7.50%
Jun 30, 20244.60M462.17K11.18%
Jun 30, 20234.14M3.05M279.61%
Jun 30, 20221.09M--
Jun 30, 2021---
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro